US Autoimmune Disease Diagnostics Market, Forecast to 2020
Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues
24-Feb-2016
North America
Market Research
9AB9-00-48-00-00
HC02380-NA-MR_16502
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.
Scope and Segmentation
Key Predictions: US Autoimmune Disease Diagnostics Market
Current Trends in the Autoimmune Disease Diagnostics Market
Autoimmune Disease Diagnostics Market—Overview
Key Companies to Watch
Ecosystem of the Autoimmune Disease Diagnostics Market
Significance of the Autoimmune Disease Diagnostics Market
Significance of the Autoimmune Disease Diagnostics Market—Prevalence Rates
Competitive Landscape
Key Diseases and Available Solutions in the US Market
Key Diseases and Available Solutions in the US Market (continued)
LDTs—Role in Autoimmune Disease Diagnostics
Segment Lifecycle Analysis by Disease
Overall Market Forecast
Overall Disease Segment Share
Competitive SWOT Analysis by Company
Competitive SWOT Analysis by Company (continued)
Where do the Opportunities Lie in this Market?
Pharma and Diagnostics Business Integration
Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels
Direct-to-Consumer Market: The Risk and The Opportunity
Localized Disease Diagnostics Segment Revenue
Growth Rate by Localized Autoimmune Diseases
Competitive Value Matrix—Localized Disease Diagnostics Segment
Autoimmune Tests—Role in Patient Continuum
Systemic Disease Diagnostics Segment Revenue
Growth Rate by Systemic Autoimmune Diseases
Competitive Value Matrix—Systemic Disease Diagnostics Segment
Autoimmune Tests—Role in Patient Continuum
Key Conclusions and Future Outlook
Legal Disclaimer
Celiac Disease-specific LDT Assays
Chron’s Disease-specific LDT Assays
RA-specific LDT Assays
Lupus-specific LDT Assays
IBD/IBS-specific LDT Assays
Others
Learn More—Next Steps
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.